Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Biomedical imaging has greatly improved understanding and treatment of solid tumors.

Pygo2 is important for early growth and progression of intestinal tumors, and could be a target for treating cancers with certain mutations.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

PHGDH promotes cancer growth by aiding cell proliferation and tumor progression.

Patched1 helps prevent tumors by controlling cell growth.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Mice with human skin protein K8 had more skin problems and cancer.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Indian Hedgehog helps control skin cell growth and protects against aggressive skin cancer.

Keratin mutations cause skin diseases and could lead to new treatments.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

New treatments for skin damage from UV light using stem cells and their secretions show promise for skin repair without major risks.

Targeting Sirt1 can reduce androgen levels and slow glioblastoma growth.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

S100A6 protein is linked to disease progression, especially in cancers.

The extracellular matrix affects where tumors can start in the body.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Exercise-induced particles can slow breast cancer growth by boosting immune response.